My research interests lie in molecular imaging and precision nuclear medicine, particularly quantitative brain PET imaging, brain network analysis, radiomics, and radiopharmaceutical therapy. My work includes neuroimaging studies of neurodegenerative disorders, quantitative imaging biomarker development, PET radiomics for disease characterization and prognosis, and patient-specific dosimetry for targeted radionuclide therapy. I am particularly interested in integrating advanced imaging analytics with theranostic approaches to enable personalized diagnosis and treatment in nuclear medicine.